NuCana

NuTide 121

NCT04163900

JCP072

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer (NuTide:121)

Status:

Closed to Accrual

26459-200.png

III

Phase

Line of Therapy.png

1st

Line of Therapy

Disease Stage.png

Advanced / Metastatic

Disease Stage

Target.png

Biomarker(s)

N/A

Investigational

Product

NUC-1031

Phosphoramidate transformation of gemcitabine

Treatment Arms

o Experimental: A - NUC-1031 and cisplatin

o Active Comparator: B - gemcitabine and cisplatin